Abstract
The aim of this chapter is to review appropriate diagnostic tests and current treatment strategies for Helicobacter pylori (H. pylori) infection. H. pylori has had an enormous impact on understanding and management of peptic ulcer disease (PUD). H. pylori infection is universally accepted as the commonest, although not the only, cause of PUD. Indeed the management of peptic ulcer now hinges on the characterization of the ulcer diathesis as H. pylori-positive or H. pylori-negative.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Howden CW, Hunt R H. (1998) Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 93: 2330–2338.
Breuer T, Goodman KJ, Malaty, HM, et al. (1998) How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol 93: 553–561.
Sharma VK, Vasudeva R, Howden CW. (1999) A survey of gastroenterologists’ perceptions and practices related to Helicobacter pylori infection. Am J Gastroenterol 94: 3170–3174.
Howden CW, Sharma VK. (1999) What is the level of understanding of primary care providers regarding Helicobacter pylori? Gastroenterology 116: A94 (Abstract).
Sharma VK, Bailey DM, Raufman J-P, et al. (1999) A survey of internal medicine residents’ opinions and practices related to H. pylori. Am J Gastroenterol 94: 1647 (Abstract).
Howden CW. (2000) What causes H. pylori-negative non-NSAID related ulcers? In: Helicobacter pylori: Basic Mechanisms to Clinical Cure, 2000. ( Hunt RH, Tytgat GNJ, eds.), Dordrecht: Kluwer Scientific.
Cutler AF, Haystad S, Ma CK, et al. (1995) Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 109: 136–141.
Cutler A, Schubert A, Schubert T. (1993) Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci 38: 2262–2266.
Marchildon P, Balaban DH, Sue M, et al. (1999) Usefulness of serological IgG antibody determination for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol 94: 2105–2108.
Chey WD, Murthy U, Shaw S, et al. (1999) A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial. Am J Gastroenterol 94: 1512–1516.
Logan RPH, Dill S, Bauer E, et al. (1991) The European 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 3: 915–921.
Peura DA, Pambianco DJ, Dye KR, et al. (1996) Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes. Am J Gastroenterol 91: 233–238.
Slomianski A, Schubert T, Cutler AF. (1995) [13C]-urea breath test to confirm eradication of Helicobacter pylori. Am J Gastroenterol 90:224–227.
Laine L, Estrada R, Trujillo M, et al. (1998) Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 129: 547–550.
Bravo LE, Realpe L, Campo C, et al. (1999) Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol 94: 2380–2383.
Sharma VK, Raufman J-P, Howden CW. (1999) To document or not to document H. pylori eradication after peptic ulcer hemorrhage? The cost question. Am J Gastroenterol 94: 2619 (Abstract).
Sharma VK, Raufman J-P, Howden CW. (1999) Is documentation of H. pylori eradication justifiable in patients with uncomplicated peptic ulcer? Am J Gastroenterol 94: 2619 (Abstract).
Cutler AF, Toskes P. (1999) Comparison of [13C] urea blood test to [13C] urea breath test for the diagnosis of Helicobacter pylori. Am J Gastroenterol 94: 959–961.
Chey WD, Murthy U, Toskes P, et al. (1999) The 13C-urea blood test accurately detects active Helicobacter pylori infection: a United States, multicenter trial. Am J Gastroenterol 94: 1522–1524.
Vaira D, Malfertheiner P, Mégraud F, et al. (1999) HpSA European study group. Diagnosis of Helicobacter pylori infection using a novel, non-invasive antigen-based assay. Lancet 354: 30–33.
Trevisani L, Sartori S, Ruina M, et al. (1999) Helicobacter pylori stool antigen test: Clinical evaluation and cost analysis of a new enzyme immunoassay. Dig Dis Sci 44: 2303–2306.
Lehmann F, Drewe J, Terracciano L, et al. (1999) Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection. Br Med J 319: 1409.
Oderda G, Rapa A, Ronchi B, et al. (2000) Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. Br Med J 320: 347–348.
Laheij RJF, van Rossum LGM, Jansen JBMJ, et al. (1999) Evaluation of treatment regimens to cure Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 13: 857–864.
Huang J-Q, Chiba N, Wilkinson JM, et al. (1997) Which combination therapy can eradicate 90% Helicobacter pylori infection? A meta-analysis of amoxicillin, metronidazole, tetracycline and clarithromycin-containing regimens. Gastroenterology 112: A19 (Abstract).
Peura DA. (1997) The report of the Digestive Health InitiativesM International Update Conference on Helicobacter pylori. Gastroenterology 113 (Suppl. 1): S4 - S8.
Huang J-Q, Hunt RH. (1999) The importance of clarithromycin dose in the treatment of H. pylori infection: a meta-analysis of comparative studies of a proton pump inhibitor, amoxicillin, and clarithromycin. Gastroenterology 116: A65 (Abstract).
de Boer WA, Tytgat GNJ. (2000) Treatment of Helicobacter pylori infection. Br Med J 320: 31–34.
Fennerty MB, Krause R, Huber M. (1998) A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of H. pylori. Arch Intern Med 158: 1651–1656.
Laine L, Estrada R, Trujillo M, et al. (1996) Randomized comparison of twicea-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 10:1029–1033.
de Boer WA, van Etten RJXM, van de Wouw BAM, et al. (2000) Bismuth-based quadruple therapy for Helicobacter pylori: a single triple capsule plus lansoprazole. Aliment Pharmacol Ther 14: 85–89.
Laine L. (2000) Bismuth-based single capsule triple therapy in North America: Interim results of a North American study of OBMT vs. OAC. In: Helicobacter pylori: Basic Mechanisms to Clinical Cure, 2000. (Hunt RH, Tytgat GNJ, eds.), Dordrecht: Kluwer Scientific, in press.
Laine L, Malone T, Bochenek W, et al. (1999) Current U.S. rates of H. pylori antibiotic resistance and factors predicting resistance: results from ongoing trials at 77 sites. Gastroenterology 116: A228 (Abstract).
Huang J-Q, Hunt RH. (1999) Impact of metronidazole-resistant H. pylori strains on PPI-based triple therapies: a meta-analysis. Gastroenterology 116:A 191(Abstract).
Houben MHMG, van de Beek D, Hensen EF, et al. (1999) A systematic review of Helicobacter pylori eradication therapy–the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 13: 1047–1055.
Fennerty MB, Lieberman DA, Vakil N, et al. (1999) Effectiveness of Helicobacter pylori therapies in a clinical practice setting. Arch Intern Med 159: 1562–1565.
Fennerty MB, Magaret N, Burn M, et al. (1999) Outcomes of treatment of H. pylori by community gastroenterologists: The GORGE II study. Gastroenterology 116: A57 (Abstract).
Sonnenberg A, Olson CA, Zhang J. (1999) The effect of antibiotic therapy on bleeding from duodenal ulcer. Am J Gastroenterol 94: 950–954.
Corder FA, Howden CW, Raufman J-P, et al. (1999) Helicobacter pylori eradication reduces the risk of recurrent peptic ulcer hemorrhage: a meta-analysis. Gastroenterology 116:A138–A139(Abstract).
Corder FA, Howden CW, Raufman J-P, et al. (1999) Helicobacter pylori eradication is superior to maintenance acid suppression for the prevention of recurrent peptic ulcer hemorrhage: ameta-analysis. Gastroenterology 116:A138(Abstract).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Howden, C.W. (2001). H. pylori-Related Diseases. In: Freston, J.W. (eds) Diseases of the Gastroesophageal Mucosa. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-103-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-103-9_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9642-0
Online ISBN: 978-1-59259-103-9
eBook Packages: Springer Book Archive